Literature DB >> 22361601

Endothelial and smooth muscle cells dysfunction distal to recanalized chronic total coronary occlusions and the relationship with the collateral connection grade.

Salvatore Brugaletta1, Victoria Martin-Yuste, Teresa Padró, Luis Alvarez-Contreras, Josep Gomez-Lara, Hector M Garcia-Garcia, Clarissa Cola, Giovanna Liuzzo, Monica Masotti, Filippo Crea, Lina Badimon, Patrick W Serruys, Manel Sabaté.   

Abstract

OBJECTIVES: This study sought to assess the vascular function in patients with chronic total coronary occlusions (CTO) immediately after successful percutaneous recanalization and its relation with the pre-existing collateral circulation.
BACKGROUND: CTOs represent a long-acting occlusion of a coronary vessel, in which the progressively developed collateral circulation may limit ischemia and symptoms. However, it is unknown if the coronary segment distal to the occlusion has a preserved vascular function.
METHODS: We prospectively enrolled 19 consecutive patients, after percutaneous coronary intervention of a CTO. Luminal diameter, measured by quantitative coronary angiography, and coronary blood flow at level of epicardial coronary artery distal to the treated CTO was assessed before and after administration of acetylcholine (Ach), adenosine, and nitroglycerin (NTG). Collaterals were assessed angiographically by grading of Rentrop and of collateral connections (CC1: threadlike continuous connection; CC2: side branch-like connection).
RESULTS: Overall, Ach and adenosine caused coronary artery vasoconstriction (p=0.001 and p=0.004, respectively), whereas NTG failed to induce vasodilation (p=0.084). Coronary blood flow significantly decreased with Ach (p=0.005), significantly increased with NTG (p=0.035), and did not change with adenosine (p=0.470). Patients with CC2 collaterals (n=8) had less vasoconstriction response and reduction in coronary blood flow after Ach (p=0.005 and p=0.008, respectively), and better vasomotor response to NTG (p=0.029) than patients with CC1 collaterals (n=11).
CONCLUSIONS: Significant endothelial and smooth muscle dysfunction is present in the distal segments of successfully recanalized CTOs, and that seems to be more pronounced in the presence of a low grading of collateral circulation.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22361601     DOI: 10.1016/j.jcin.2011.10.012

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  8 in total

Review 1.  Contemporary overview and clinical perspectives of chronic total occlusions.

Authors:  Loes P Hoebers; Bimmer E Claessen; George D Dangas; Truls Råmunddal; Roxana Mehran; José P S Henriques
Journal:  Nat Rev Cardiol       Date:  2014-05-27       Impact factor: 32.419

Review 2.  The dynamics of the coronary collateral circulation.

Authors:  Marco Zimarino; Mariangela D'Andreamatteo; Ron Waksman; Stephen E Epstein; Raffaele De Caterina
Journal:  Nat Rev Cardiol       Date:  2014-01-07       Impact factor: 32.419

3.  Dihydrotestosterone modulates endothelial progenitor cell function via RhoA/ROCK pathway.

Authors:  Hao Zhang; Liang Shi; Guo-Qing Ren; Wen-Wen Sun; Yi-Bin Wang; Yi-Kun Chen; Jiang-Ning Yin; Bing Wan
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

4.  Effects of dihydrotestosterone on adhesion and proliferation via PI3-K/Akt signaling in endothelial progenitor cells.

Authors:  Rui Liu; Li Ding; Ming-Hua Yu; Han-Qin Wang; Wen-Chun Li; Zheng Cao; Peng Zhang; Bo-Chun Yao; Jie Tang; Qing Ke; Tie-Zhu Huang
Journal:  Endocrine       Date:  2013-11-05       Impact factor: 3.633

Review 5.  Coronary chronic total occlusion intervention: A pathophysiological perspective.

Authors:  Debabrata Dash
Journal:  Indian Heart J       Date:  2018-01-10

6.  Recovery of Absolute Coronary Blood Flow and Microvascular Resistance After Chronic Total Occlusion Percutaneous Coronary Intervention: An Exploratory Study.

Authors:  Daniëlle C J Keulards; Grigoris V Karamasis; Osama Alsanjari; Jesse P A Demandt; Marcel Van't Veer; Jo M Zelis; Simon A Dello; Mohamed El Farissi; Klio Konstantinou; Kare H Tang; Paul A Kelly; Thomas R Keeble; Nico H J Pijls; John R Davies; Koen Teeuwen
Journal:  J Am Heart Assoc       Date:  2020-04-22       Impact factor: 5.501

7.  rs41291957 controls miR-143 and miR-145 expression and impacts coronary artery disease risk.

Authors:  Ignacio Fernando Hall; Montserrat Climent; Chiara Viviani Anselmi; Laura Papa; Vinicius Tragante; Luca Lambroia; Floriana Maria Farina; Marcus E Kleber; Winfried März; Carlo Biguori; Gianluigi Condorelli; Leonardo Elia
Journal:  EMBO Mol Med       Date:  2021-09-22       Impact factor: 12.137

Review 8.  CTO pathophysiology: how does this affect management?

Authors:  John Irving
Journal:  Curr Cardiol Rev       Date:  2014-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.